4% of drugs registered 2000-11 for NTDs; 4 NCEs

“Of the 850 new therapeutic products registered in 2000–11, 37 (4%) were indicated for neglected diseases,
comprising 25 products with a new indication or formulation and eight vaccines or biological products. Only four
new chemical entities were approved for neglected diseases (three for malaria, one for diarrhoeal disease), accounting
for 1% of the 336 new chemical entities approved during the study period. Of 148 445 clinical trials registered in
Dec 31, 2011, only 2016 (1%) were for neglected diseases.”


Lancet, Dec 2013


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s